News & Updates
Filter by Specialty:
Coexisting diabetes ups risk of secondary malignancy, death in cancer patients
In cancer patients, the presence of diabetes appears to aggravate the likelihood of developing a secondary malignancy or death, reports a recent Japan study.
Coexisting diabetes ups risk of secondary malignancy, death in cancer patients
15 Dec 2022Carotid atherosclerosis ups risk of small fibre nerve dysfunction in T2D
Among patients with type 2 diabetes (T2D), the presence of carotid atherosclerosis appears to aggravate the risk of developing small fibre nerve dysfunction, a recent study has found.
Carotid atherosclerosis ups risk of small fibre nerve dysfunction in T2D
14 Dec 2022Diabetes and COVID-19: What have we learned so far?
Evidence for excess risk and increased burden of new-onset diabetes among COVID-19 survivors is robust, and most antihyperglycaemic drugs can be used safely during acute COVID-19, with some drugs potentially offering protection against serious complications, according to data presented at 5th EDM HK.
Diabetes and COVID-19: What have we learned so far?
09 Dec 2022Will a bedtime snack help treat hyperglycaemia in type 2 diabetes?
There is no convincing benefit to consuming a bedtime snack for glycaemic control in individuals with type 2 diabetes (T2D) or prediabetes, according to the results of a systematic review.
Will a bedtime snack help treat hyperglycaemia in type 2 diabetes?
02 Dec 2022Maximum home BP predicts cardiovascular outcomes in T2D patients
In patients with type 2 diabetes (T2D), maximum home blood pressure (BP) may be used as a potential marker of subsequent cardiovascular events, suggests a retrospective cohort study.
Maximum home BP predicts cardiovascular outcomes in T2D patients
02 Dec 2022Pituitary TF–based classification improves diagnostic accuracy and prognostication of nonfunctioning PitNETs
Utility of pituitary transcription factors (TFs) improves the diagnostic accuracy and prognostication of nonfunctioning pituitary neuroendocrine tumours (NF-PitNETs), according to local data and a new diagnostic classification presented at the 5th Annual Meeting of Endocrinology, Diabetes & Metabolism Hong Kong (EDM HK).